Related Experiment Video
Updated: Jul 31, 2026

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
Published on: July 30, 2009
Ethical and cross cultural questions concerning pediatric clinical trials
D Pilpel1, F J Leavitt, E Elizur-Leiberman
1Unit of Epidemiology and Evaluation of Health Services, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Insights
This study explores ethical issues in using recombinant growth hormone for children with short stature. It questions informed consent, decision-making autonomy, and potential psychological dependence during long-term treatment.
Area of Science:
- Pediatric Endocrinology
- Bioethics
- Clinical Trials
Background:
- Recombinant growth hormone (rGH) therapy is used for children with short stature.
- Ethical considerations arise regarding the use of rGH in otherwise healthy children.
Purpose of the Study:
- To identify and discuss the ethical dilemmas encountered during a clinical trial of rGH in short, healthy children.
- To examine issues of informed consent, patient autonomy, and long-term psychological effects.
Main Methods:
- The study involved a clinical trial of rGH in a cohort of children with short stature.
- Ethical problems were identified and discussed in a cross-cultural context.
Main Results:
- Key ethical challenges include balancing benefits and risks, ensuring true informed consent from parents and children, and determining decision-making capacity.
- Concerns were raised about psychological dependence on medical professionals and the child's freedom to withdraw from long-term treatment.
Conclusions:
- The use of rGH in children necessitates careful consideration of complex ethical issues, including patient autonomy and the definition of medical necessity versus cosmetic concerns.
- A cross-cultural perspective is crucial for navigating these ethical dilemmas in pediatric treatment decisions.
Abstract:
During a clinical trial of recombinant growth hormone in a population of short stature but otherwise healthy children the following ethical problems were confronted: What are the prospective benefits compared with the foreseeable risks associated with this therapy? Can the doctor really inform the parent and/or the child about the outcomes of the treatment? Who must make the decision about participation in the trial? From which age can the child himself decide about continuing or dropping out? Since the treatment requires frequent check-ups for years, to what extent does the child become psychologically dependent upon the medical profession? Given this possibility, is the child really free to withdraw from the treatment? Is there a conflict between the doctor's autonomy to propose the treatment and the patient's autonomy to decide about participation? Is there a clear threshold between life-threatening problems and minor, cosmetic problems? These dilemmas are discussed in a cross-cultural context.
More Related Videos
08:10Neuroimaging Field Methods Using Functional Near Infrared Spectroscopy (NIRS) Neuroimaging to Study Global Child Development: Rural Sub-Saharan Africa
Published on: February 2, 2018
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Related Concept Videos
Ethics in Research
Clinical Trials
There are four phases in a clinical trial. A phase one...
Ethical Issues
Ethical Concerns in Healthcare:
Ethical Dilemmas I
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...
Ethical Dilemmas II
Clinical Trials: Overview